Europe’s installed biomethane production capacity has passed 8 bcm per year for the first time, reaching 8.2 bcm/year at the end of Q2 2026 after more than 1 bcm of additions in twelve months, a 17% expansion on 2025. The figure comes from the seventh edition of the European Biomethane Map, published jointly by Gas Infrastructure Europe and the European Biogas Association, and it arrives alongside a second data point of at least equal weight for the desk: the sector’s declared investment pipeline has climbed to €36 billion, up from the €28.4 billion the EBA identified in mid-2025, with developers increasingly citing the EU carbon price as the variable that closes their business cases.
A build-out that is accelerating, not merely continuing
The plant count tells the same story as the capacity number. The European fleet grew from 1,678 to 1,974 facilities over the past year, with 327 new plants commissioned. That commissioning rate is roughly double the 165 plants added in the preceding twelve-month cycle, when capacity stood at 7 bcm/year at the end of Q1 2025 and annual growth ran at 9%. The sector has, in other words, moved from a high-single-digit growth regime to one adding a full bcm of capacity per year.
The investment side has re-rated in parallel. The EBA’s June 2025 outlook recorded €28.4 billion of allocated capital, projected to deliver an additional 7.3 bcm/year of capacity by 2030. A pipeline of €36 billion one year later represents growth of roughly 27%, a sharper acceleration than the €1 billion year-on-year increment recorded between the 2024 and 2025 surveys. Capital formation in the sector, which had been drifting, is now compounding.
The carbon price has become the revenue model
What has changed is not feedstock economics but the demand-side arithmetic. The first waves of European biomethane were built on national feed-in schemes; the current wave is increasingly underwritten by the value of avoided EUA surrender for ETS installations and, from 2027, avoided ETS2 exposure for fuel suppliers in buildings and road transport. The recognition of biomethane within the EU ETS is already fostering long-term biomethane purchase agreements, and the phase-out of free allocation is strengthening the fuel’s appeal on the demand side. In Spain, the country holding the largest single national investment pipeline, projects are being de-risked primarily through long-term commercial purchase agreements rather than tariffs.
The read here is that the sector’s revenue stack has quietly migrated from national budgets onto the EU carbon price curve. That is a structural improvement in scalability, since it removes the fiscal ceiling that capped tariff-driven growth in Germany and France. It also means the €36 billion pipeline is, in effect, a leveraged long position on the carbon price path. The sensitivity now runs both ways.
Certification and infrastructure remain the binding constraints
The industry’s own framing of the milestone was notably unceremonious. EBA chief executive Harmen Dekker said uncertainty and regulatory complexity continue to hold the sector back, pointing to feedstock access, permitting speed, and the harmonisation of certification and trade as the areas needing action. GIE, for its part, stressed that production sits in rural areas while demand concentrates in cities and industrial clusters, and called for greater transparency on grid access, injection requirements and available capacity under the EU Biomethane Mechanism. The molecule is being built faster than the market architecture that lets it circulate.
What this means for originators and obligated buyers
Three consequences follow. First, the gap between physical capacity growth and tradability is widening, and the value is migrating to whoever can bridge it. Cross-border monetisation still runs through a fragmented certification landscape, and the Union Database only becomes the mandatory tracking backbone for renewable gases in the course of 2026. Until that settles, structuring capability, mass-balance logistics and clean proof-of-sustainability chains will command a premium over the commodity itself, which favours OTC intermediation over exchange-style venues. It is telling that the Commission is still only evaluating the feasibility of a trading platform for non-fossil gaseous molecules, modelled on AggregateEU, a design that by construction does not do price discovery or execution.
Second, the marginal buyer is about to change. With ETS2 compliance beginning to bite from 2027, obligated fuel suppliers in heating and road transport join industry as structural demand, and their willingness to pay is set by the ETS2 price rather than by voluntary green premiums. Portfolio hedging of that exposure with certified molecules becomes a compliance strategy, not a marketing one.
Third, the risk transfer cuts both ways. A pipeline financed against carbon price expectations is exposed to precisely the political interventions that pipeline did not face when it lived on national tariffs. Any move to soften ETS2 price formation ahead of launch would now propagate directly into biomethane final investment decisions. On our reading, the sector has traded fiscal risk for regulatory price risk, and the 2030 supply picture, still far short of the 35 bcm the Commission’s REPowerEU framework calls for, will be decided by which of the two proves more stable.
